Could a TCR be faster than a CAR?

Blood 2026 Open access

Read full text

Authors: Fateeha Furqan, Paolo Strati

DOI: 10.1182/blood.2025031787

Cited by: 0

References: 10

Abstract

registrational trial (65 U/m 2 on days 1 and 3), perhaps suggesting that the chemosensitive disease may not require such dose intensity.

CAR-T cell therapy research Immunotherapy and Immune Responses T-cell and B-cell Immunology

References 10